DK1030659T3 - Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist - Google Patents

Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist

Info

Publication number
DK1030659T3
DK1030659T3 DK98956561T DK98956561T DK1030659T3 DK 1030659 T3 DK1030659 T3 DK 1030659T3 DK 98956561 T DK98956561 T DK 98956561T DK 98956561 T DK98956561 T DK 98956561T DK 1030659 T3 DK1030659 T3 DK 1030659T3
Authority
DK
Denmark
Prior art keywords
ephedrine
receptor antagonist
pharmaceutical preparation
preparation containing
substantially free
Prior art date
Application number
DK98956561T
Other languages
English (en)
Inventor
Anthony R Booth
Peter Raven
James L Caffrey
Thomas Yorio
Michael Forster
Patricia Gwirtz
William T Sherman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1030659T3 publication Critical patent/DK1030659T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98956561T 1997-11-14 1998-11-04 Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist DK1030659T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6557297P 1997-11-14 1997-11-14
PCT/US1998/023479 WO1999025328A1 (en) 1997-11-14 1998-11-04 (+)-ephedrine as a sympathomimetic drug

Publications (1)

Publication Number Publication Date
DK1030659T3 true DK1030659T3 (da) 2003-09-15

Family

ID=22063647

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956561T DK1030659T3 (da) 1997-11-14 1998-11-04 Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist

Country Status (8)

Country Link
EP (1) EP1030659B1 (da)
AT (1) ATE240097T1 (da)
AU (1) AU1305999A (da)
DE (1) DE69814669T2 (da)
DK (1) DK1030659T3 (da)
ES (1) ES2199474T3 (da)
PT (1) PT1030659E (da)
WO (1) WO1999025328A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1314199B1 (it) * 1999-10-20 2002-12-06 Ambros Pharma S R L Composizioni contenenti sostanze ad attivita' adrenergica ed estrattivegetali per il trattamento del sovrappeso e obesita'
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme

Also Published As

Publication number Publication date
EP1030659A1 (en) 2000-08-30
AU1305999A (en) 1999-06-07
ATE240097T1 (de) 2003-05-15
DE69814669D1 (de) 2003-06-18
PT1030659E (pt) 2003-09-30
DE69814669T2 (de) 2003-11-27
EP1030659B1 (en) 2003-05-14
ES2199474T3 (es) 2004-02-16
WO1999025328A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
NZ509028A (en) Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
GEP20002013B (en) Therapeutical Means
CA2260943A1 (en) Formulation of 5-ht agonists
IL76932A (en) Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
ES8505519A1 (es) Un procedimiento para la preparacion de 14-fluoromorfinanos utiles como analgesicos, narcoticos y-o agentes anorexicos.
NZ319531A (en) An analgesic synergistic composition containing a sub-analgesic dose of a mu opioid agonist and a kappa-2 opiod agonist
FR2673538B1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
PL321498A1 (en) Pharmaceutic agent for use against urine incontinence and method of obtaining (s)-desethyloxybutinine
MX9706449A (es) Composicion farmaceutica para compuestos de piperidinalcanol.
HU1500214D0 (hu) Opioid agonista és antagonista hatóanyagot tartalmazó gyógyszerkészítmény
HUP0204163A2 (hu) Opioid agonistát és antagonistát tartalmazó szabályozott leadású készítmény és eljárás az előállítására
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
DE60019334D1 (de) Antivirale arznei
SI1572167T1 (sl) Transdermalni buprenorfinski dozirni reĹľim za analgezijo
FR2735369B1 (fr) Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
AU7284098A (en) Method for preventing gastritis using amylin or amylin agonists
GB9721746D0 (en) Compositions
TW231970B (da)
DK1030659T3 (da) Farmaceutisk præparat indeholdende (+)-efedrin og en H1-receptor antagonist
HK1026843A1 (en) Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x.
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
GEP20043313B (en) Use of Pharmaceutical Composition for Treatment of Endometriosis or Infertility, or Improving Fertility